Mitochondrial biogenesis: pharmacological approaches.
Valero T.
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
Mitochondrial Retinopathy.
Birtel J, von Landenberg C, Gliem M, Gliem C, Reimann J, Kunz WS, Herrmann P, Betz C, Caswell R, Nesbitt V, Kornblum C, Charbel Issa P.
Ophthalmol Retina. 2022 Jan;6(1):65-79. doi: 10.1016/j.oret.2021.02.017. Epub 2021 Jul 10.
[Pituitary incidentaloma].
Kršek M.
Vnitr Lek. 2022 Summer;68(2):127-130.
Oculomotor palsy in diabetics.
Lajmi H, Hmaied W, Ben Jalel W, Chelly Z, Ben Yakhlef A, Ben Zineb F, El Fekih L.
J Fr Ophtalmol. 2018 Jan;41(1):45-49. doi: 10.1016/j.jfo.2017.06.010. Epub 2017 Dec 28.
Retinopathy in patients with diabetic ophthalmoplegia.
Trigler L, Siatkowski RM, Oster AS, Feuer WJ, Betts CL, Glaser JS, Schatz NJ, Farris BK, Flynn HW.
Ophthalmology. 2003 Aug;110(8):1545-50. doi: 10.1016/S0161-6420(03)00542-6.
Retinopathy in patients with diabetic ophthalmoplegia.
Acaroglu G, Akinci A, Zilelioglu O.
Ophthalmologica. 2008;222(4):225-8. doi: 10.1159/000130070. Epub 2008 May 8.
Mitochondrial diabetes mellitus.
Rötig A, Bonnefont JP, Munnich A.
Diabetes Metab. 1996 Oct;22(5):291-8.
Risk Factors of Rhino Orbital Mucormycosis.
Patade Y, G R.
Cureus. 2022 Dec 30;14(12):e33145. doi: 10.7759/cureus.33145. eCollection 2022 Dec.
Assessment of the prevalence and risk factors of ophthalmoplegia among diabetic patients in a large national diabetes registry cohort.
Al Kahtani ES, Khandekar R, Al-Rubeaan K, Youssef AM, Ibrahim HM, Al-Sharqawi AH.
BMC Ophthalmol. 2016 Jul 22;16:118. doi: 10.1186/s12886-016-0272-7.
Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
Watanabe A, So M, Mitaka H, Ishisaka Y, Takagi H, Inokuchi R, Iwagami M, Kuno T.
Mycopathologia. 2022 Jun;187(2-3):271-289. doi: 10.1007/s11046-022-00627-8. Epub 2022 Mar 21.
